Journal
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
Volume 18, Issue 1, Pages 21-37Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1871520616666160811113531
Keywords
1,2,3-triazoles; 1,4-disubstituted 1H-1,2,3-triazoles; click chemistry; anticancer agents; nitrogen; chemtherapy
Categories
Funding
- Haryana State counseling Society
Ask authors/readers for more resources
Cancer is a class of formidable disease with high degree of mortality. Despite much progress in chemotherapy, the problem of drug resistance has led to the search for newer leads with superior efficacy. 1,2,3-Triazoles are among a vast number of nitrogen containing heterocycles studied extensively as pharmacologically important scaffolds. Recently developed copper(I)-catalyzed cycloaddition reaction between organic azides and terminal alkynes yielding 1,4-disubstituted 1,2,3-triazoles has attracted considerable attention because it allows the construction of a vast array of 1,2,3-triazoles with significant potential in pharmaceutical chemistry. In this article, an attempt to summarize the wide range of anticancer agents derived from copper(I)-catalyzed azide alkyne cycloaddition reported by the authors worldwide, has been made. This review includes articles published from 2010 onwards and summarizes the recent progress on the development of 1,4-disubstituted 1H-1,2,3-triazoles as novel anticancer chemotypes with high therapeutic indices.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available